Literature DB >> 30913548

Impact of cardiac resynchronisation therapy on cardiologists' exposure to radiation during implantation of pacemakers and implantable cardioverter-defibrillators.

Charline Daval1, Laurent Faroux, François Lesaffre, Thierry Blanpain, Jean-Pierre Chabert, Angeline Martin, Mathias Guinot, Nicolas Luconi, Madeline Espinosa, Pierre Nazeyrollas, Christophe Tourneux, Damien Metz.   

Abstract

Cardiologists are among the health professionals that are most exposed to ionizing radiation, but there is no recent study quantifying overexposure of physicians during cardiac resynchronisation therapy (CRT) procedures compared to 'classical' implantation of pacemakers (PMs) or implantable cardioverter-defibrillators (ICDs). We aimed to measure and compare operator exposure to radiation during implantation of PM and ICD with or without CRT. The study population comprised all PMs and ICDs implanted in a large referral centre over a six months period. The endpoint was operator radiation exposure, assessed using a personal electronic dosimeter located on operator's chest. In total, 169 PM/ICD implantations were analysed, 19 of which included CRT. Compared with 'classical' implantation, cardiologist radiation exposure was 9-fold greater during CRT procedures (p < 0.001). Physician exposure was related to dose-area product (R2 = 0.21 during 'classical' implantations and R2 = 0.57 during CRT procedures). Our study shows that cardiologists' exposure to radiation during CRT implantation was 9-fold greater than during procedures without CRT.

Entities:  

Year:  2019        PMID: 30913548     DOI: 10.1088/1361-6498/ab1377

Source DB:  PubMed          Journal:  J Radiol Prot        ISSN: 0952-4746            Impact factor:   1.394


  1 in total

1.  Aegrescit medendo: orthopedic disability in electrophysiology - call for fluoroscopy elimination-review and commentary.

Authors:  Donald S Rubenstein; Benjamin B Holmes; Joseph A Manfredi; Matthew S McKillop; Peter C Netzler; Chad C Ward
Journal:  J Interv Card Electrophysiol       Date:  2022-03-08       Impact factor: 1.759

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.